Arcadia Biosciences, Inc. · NASDAQ:RKDA
Arcadia Biosciences — Bank of America Merrill Lynch Global Agriculture and Chemicals Conference 2016
9 slides from Arcadia Biosciences's conference presentation, Mar 3, 2016
Slide 1: Bank of America Merrill Lynch Global Agriculture and Chemicals Conference
Bank of America Merrill Lynch Global Agriculture and Chemicals Conference March 3, 2016
Slide 2: Forward-looking statements
Forward-looking statements “Safe Harbor” statement under the Private Securities Litigation Reform Act of 1995: This presentation c ontains forward-looking statements about the company and its products, including statements relating to components of the company’s long-term financial success;; the
Slide 3: Arcadia is creating next wave of value in untapped agricultural markets
Arcadia is creating next wave of value in untapped agricultural markets Leading ag-biotech trait company with more than a decade of global experience developing GM and non-GM traits Catalytic role: We bridge and de-risk the gap Arcadia’s Target Space between basic research and commercial developm
Slide 4: Open architecture maximizes technology access and global market penetration
Open architecture maximizes technology access and global market penetration Public Institutions Arcadia Licensees Gene Proof of Transform Field t rial Transform Product Regulatory Seed Activities discovery concept into crops data into t arget development approval marketing crops and sales Rice Wheat
Slide 5: Arcadia employs a range of technologies to address growers' needs
Arcadia employs a range of technologies to address growers’ needs Site-Specific Modification of Technology Genetic Modification (GM) TILLING Naturally Existing Genes Function • Agrobacterium used for • Agrobacterium used with • Arcadia’s proprietary gene transfer crispr-Cas for gene seed random-
Slide 6: Benefits from TILLING underpin Arcadia's R&D success
Benefits from TILLING underpin Arcadia’s R&D success Targeting Induced Local Lesions IN Genomes Discovery of new genetic diversity Source of novel Benefits Effective phenotypes applications • Starch composition • Non-GM, single • Knockout gene nucleotide changes function • Fiber • Insight into gene
Slide 7: TILLING overview
TILLING overview M1 M2 Mutagen seed$bank$library 14,300$bread$&$9,800$durum$ TILLING$lines Arcadia has developed methods to create plant populations optimized for high density gene diversity within the crop genome. DNA$library Thousands of lines are maintained at our California site in the forms of
Slide 8: Key patent issued for non-GM Resistant Starch Wheat that improves health qualities of wheat
Key patent issued for non-GM Resistant Starch Wheat that improves health qualities of wheat Resistant Starch Wheat (non-GM) Market Potential Value Creation DEVELOPMENT PHASE / PROBABILITY OF SUCCESS • Global • Based on delivery of greater D 1 2 3 4 C • $2B market opportunity total dietary fiber in
Slide 9: Non-GM Reduced Gluten Wheat expands grain use in $2B+ market
Non-GM Reduced Gluten Wheat expands grain use in $2B+ market Reduced Gluten Wheat (non-GM) Market Potential Value Creation DEVELOPMENT PHASE / PROBABILITY OF SUCCESS • Global • Based on gluten reduction in D 1 2 3 4 C • $2.1 B market opportunity wheat products 24-48 mo 12-24 mo 12-24 mo 12-24